These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 10820352
21. Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density. Emoto M, Iwasaki H, Mimura K, Kawarabayashi T, Kikuchi M. Cancer; 1997 Sep 01; 80(5):899-907. PubMed ID: 9307190 [Abstract] [Full Text] [Related]
24. Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening. Carter JR, Lau M, Fowler JM, Carlson JW, Carson LF, Twiggs LB. Am J Obstet Gynecol; 1995 Mar 01; 172(3):901-7. PubMed ID: 7892883 [Abstract] [Full Text] [Related]
25. Preoperative evaluation of cystic teratoma: what does color Doppler add? Kurjak A, Kupesic S, Babic MM, Goldenberg M, Illijas M, Kosuta D. J Clin Ultrasound; 1997 Mar 01; 25(6):309-16. PubMed ID: 9142626 [Abstract] [Full Text] [Related]
26. [Color Doppler blood flow measurements and microvessel density assessment in ovarian tumors]. Czekierdowski A, Szymański M, Szumiło J, Kotarski J. Ginekol Pol; 2003 Sep 01; 74(9):695-700. PubMed ID: 14674110 [Abstract] [Full Text] [Related]
29. Preoperative diagnosis of malignant transformation in mature cystic teratoma of the ovary. Yamanaka Y, Tateiwa Y, Miyamoto H, Umemoto Y, Takeuchi Y, Katayama K, Hashimoto K. Eur J Gynaecol Oncol; 2005 Sep 01; 26(4):391-2. PubMed ID: 16122185 [Abstract] [Full Text] [Related]
30. Can malignant transformation in mature cystic teratoma be preoperatively predicted? Futagami M, Yokoyama Y, Mizukami H, Shigeto T, Mizunuma H. Eur J Gynaecol Oncol; 2012 Sep 01; 33(6):662-5. PubMed ID: 23327068 [Abstract] [Full Text] [Related]
31. Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K, Tanabe H, Watanabe A, Ochiai K, Tanaka T. Gynecol Oncol; 2003 Aug 01; 90(2):338-41. PubMed ID: 12893196 [Abstract] [Full Text] [Related]
32. [Value of transvaginal color Doppler flow imaging conjugated with multiple serum tumor markers in diagnosis of ovarian tumors]. Wang Y, Liu LZ, Zhou JH, Pei XQ, Chen XY. Ai Zheng; 2004 Nov 01; 23(11 Suppl):1585-8. PubMed ID: 15566685 [Abstract] [Full Text] [Related]
34. Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors. Chou CY, Chang CH, Yao BL, Kuo HC. J Clin Ultrasound; 1994 Oct 01; 22(8):491-6. PubMed ID: 7814654 [Abstract] [Full Text] [Related]
36. A multivariate logistic regression analysis in predicting malignancy for patients with ovarian tumors. Hata K, Akiba S, Hata T, Miyazaki K. Gynecol Oncol; 1998 Mar 01; 68(3):256-62. PubMed ID: 9570977 [Abstract] [Full Text] [Related]
37. The use of serum TA-4 in monitoring patients with malignant transformation of ovarian mature cystic teratoma. Kimura T, Inoue M, Miyake A, Tanizawa O, Oka Y, Amemiya K, Mineta H, Neki R, Nishino H, Morishige K. Cancer; 1989 Jul 15; 64(2):480-3. PubMed ID: 2736493 [Abstract] [Full Text] [Related]
39. Color Doppler Ultrasound in the pre-histological determination of the biological character of major salivary gland tumors. Strympl P, Kodaj M, Bakaj T, Kominek P, Starek I, Sisola I, Tomaskova H, Matousek P. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep 15; 158(3):465-9. PubMed ID: 23073538 [Abstract] [Full Text] [Related]